Results for tag: "Direct To Consumer Microbiome Analyzing"

In the field of biotechnology, the direct-to-consumer (DTC) microbiome analyzing market encompasses businesses that offer personal health services by analyzing the microbiome - the collection of microorganisms, such as bacteria, fungi, and viruses, that inhabit various parts of the human body. The primary focus of these services is to provide insights into an individual's gut flora. This personalization of health care is facilitated through advances in genome sequencing technologies, bioinformatics, and an increased interest in personalized medicine. Consumers can collect a sample using a home testing kit and send it to a company for analysis. In return, they receive detailed reports that may suggest dietary changes, probiotic recommendations, or even lifestyle adjustments, aimed at improving gut health, which is often linked to a plethora of health outcomes. Several companies offering DTC microbiome analyzing services are active in the market. Some reputed players include uBiome (which filed for bankruptcy in 2019 and no longer operates), Viome, Thryve, American Gut (a project by the Human Food Project), and DayTwo. These companies vary in the range of microbial analysis they provide, as well as the level of personalization and health recommendations they offer based on the analysis of microbiome composition. Show Less Read more